BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 22664113)

  • 1. Interleukin-8 in the pathogenesis of primary central nervous system lymphoma in association with HIV infection.
    Sasakawa A; Hirase C; Yamaguchi T; Morita Y; Miyatake J; Matsumura I; Maeda Y
    Hematology; 2012 May; 17(3):144-50. PubMed ID: 22664113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma.
    Bossolasco S; Falk KI; Ponzoni M; Ceserani N; Crippa F; Lazzarin A; Linde A; Cinque P
    Clin Infect Dis; 2006 Feb; 42(4):e21-5. PubMed ID: 16421782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS-related primary central nervous system lymphoma.
    Kasamon YL; Ambinder RF
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):665-87, vi-vii. PubMed ID: 16083829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immortalized Epstein-Barr virus-positive B-cell lines obtained by prolonged culture of peripheral blood mononuclear cells from human immunodeficiency virus type 1-positive patients.
    Ruibal-Ares B; Belmonte L; Baré P; Scolnik M; Palacios MF; Bayo-Hanza C; Galmarini CM; Mendez G; de Bracco MM
    J Hum Virol; 2001; 4(4):200-13. PubMed ID: 11694848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection of Epstein-Barr virus-transformed lymphoblastoid B cells by the human immunodeficiency virus: evidence for a persistent and productive infection leading to B cell phenotypic changes.
    De Rossi A; Roncella S; Calabro ML; D'Andrea E; Pasti M; Panozzo M; Mammano F; Ferrarini M; Chieco-Bianchi L
    Eur J Immunol; 1990 Sep; 20(9):2041-9. PubMed ID: 2170147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
    Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
    Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients.
    Correa RM; Fellner MD; Durand K; Redini L; Alonio V; Yampolsky C; Colobraro A; Sevlever G; Teyssié A; Benetucci J; Picconi MA
    J Med Virol; 2007 Apr; 79(4):401-7. PubMed ID: 17311329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV)-associated primary central nervous system lymphoma: is incidence of EBV expression associated with median survival time?
    Utsuki S; Oka H; Miyajima Y; Kijima C; Yasui Y; Fujii K
    Brain Tumor Pathol; 2011 Apr; 28(2):145-9. PubMed ID: 21327439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus in monitoring the response to therapy of acquired immunodeficiency syndrome-related primary central nervous system lymphoma.
    Antinori A; Cingolani A; De Luca A; Gaidano G; Ammassari A; Larocca LM; Ortona L
    Ann Neurol; 1999 Feb; 45(2):259-61. PubMed ID: 9989631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological and phenotypical changes in EBV positive lymphoblastoid cells infected by HIV-1.
    De Rossi A; Calabro ML; D'Andrea E; Panozzo M; Saggiori D; Mammano F; Roncella S; Ferrarini M; Chieco-Bianchi L
    Leukemia; 1992; 6 Suppl 3():38S-40S. PubMed ID: 1318475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4-Positive T-Cell Primary Central Nervous System Lymphoma in an HIV Positive Patient.
    Nael A; Walavalkar V; Wu W; Nael K; Kim R; Rezk S; Zhao X
    Am J Clin Pathol; 2016 Feb; 145(2):258-65. PubMed ID: 27124906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid Epstein-Barr virus detection preceding HIV-associated primary central nervous system lymphoma by 17 months.
    al-Shahi R; Bower M; Nelson MR; Gazzard BG
    J Neurol; 2000 Jun; 247(6):471-2. PubMed ID: 10929280
    [No Abstract]   [Full Text] [Related]  

  • 13. B cells from HIV-infected patients with primary central nervous system lymphoma display an activated phenotype and have a blunted TNF-α response to TLR9 triggering.
    Audigé A; Schlaepfer E; von Wyl V; Miller RC; Vernazza P; Nadal D; Speck RF;
    AIDS Res Hum Retroviruses; 2010 Oct; 26(10):1063-74. PubMed ID: 20963937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus and AIDS-related primary central nervous system lymphoma. Viral detection by immunohistochemistry, RNA in situ hybridization, and polymerase chain reaction.
    Guterman KS; Hair LS; Morgello S
    Clin Neuropathol; 1996; 15(2):79-86. PubMed ID: 8925601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2.
    Raez L; Cabral L; Cai JP; Landy H; Sfakianakis G; Byrne GE; Hurley J; Scerpella E; Jayaweera D; Harrington WJ
    AIDS Res Hum Retroviruses; 1999 May; 15(8):713-9. PubMed ID: 10357467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas.
    Martini M; Capello D; Serraino D; Navarra A; Pierconti F; Cenci T; Gaidano G; Larocca LM
    J Infect; 2007 Mar; 54(3):298-306. PubMed ID: 16784778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphoma.
    Miyauchi K; Urano E; Yoshiyama H; Komano J
    Cancer Sci; 2011 Jun; 102(6):1236-41. PubMed ID: 21392167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene-modified spontaneous Epstein-Barr virus-transformed lymphoblastoid cell lines as autologous cancer vaccines: mutated p21 ras oncogene as a model.
    Kubuschok B; Cochlovius C; Jung W; Schmits R; Trümper L; Hartmann F; Renner C; Pfreundschuh M
    Cancer Gene Ther; 2000 Sep; 7(9):1231-40. PubMed ID: 11023195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.
    Roychowdhury S; Peng R; Baiocchi RA; Bhatt D; Vourganti S; Grecula J; Gupta N; Eisenbeis CF; Nuovo GJ; Yang W; Schmalbrock P; Ferketich A; Moeschberger M; Porcu P; Barth RF; Caligiuri MA
    Cancer Res; 2003 Mar; 63(5):965-71. PubMed ID: 12615710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.